Chimeric Antigen Receptor (CAR) T-cell Therapy Market Size, Share, Trends, Demand, Growth and Competitive Analysis| MarkNtel
Chimeric Antigen Receptor (CAR) T-cell
Therapy Market Overview: 2022-28
Base Year: 2021
Historical Years: 2017-20
Forecast Years: 2022-27
The Chimeric Antigen Receptor (CAR) T-cell
Therapy Market is
projected to register exponential CAGR during the forecast period, i.e.,
2022-27. The growth of the market would be driven primarily by the burgeoning
adoption of CAR T-cell therapy to address the rising patient pool for blood
cancers, including lymphomas, certain forms of leukemia, & also multiple
myeloma, on account of the mounting awareness regarding its benefits over
traditional treatments.
Markntel Advisor’s
Chimeric Antigen Receptor (CAR) T-cell
Therapy Market Insights report provides the current and forecast market
analysis, individual leading companies' market shares, challenges, Chimeric
Antigen Receptor (CAR) T-cell Therapy Market drivers, barriers, Chimeric
Antigen Receptor (CAR) T-cell Therapy Market Trends, and Key Players in Chimeric
Antigen Receptor (CAR) T-cell Therapy Market.
Download a sample copy of the Report:
https://www.marknteladvisors.com/query/request-sample/car-t-cell-therapy-market.html
✅In
case you missed it, we are currently revising our reports. Click on the below
to get the latest research data with forecast for years 2025 to 2030, including
market size, industry trends, and competitive analysis. It wouldn’t take long
for the team to deliver the most recent version of the report.
Chimeric Antigen Receptor (CAR) T-cell
Therapy Market Dynamics: 2022-27
Mounting Incidence
of B-Cell Lymphoma & Improved Prognosis using Advanced Therapeutics: The
growing patient pool for blood cancers, especially B-cell lymphomas, i.e.,
instigating the need for better clinical & therapeutic patient outcomes in
refractory or relapsed cases, is the prime aspect projected to drive the Global
Chimeric Antigen Receptor (CAR) T-cell Therapy Market during 2022-27. Moreover,
rigorous R&D activities in developing efficient therapeutics for
Non-Hodgkin Lymphoma have led to an overall improved prognosis. It, in turn, is
driving more individuals toward adopting advanced treatments, which further
projects remunerative prospects for the global market over the forecast years.
Browse Full Report with Detail Analysis -
https://www.marknteladvisors.com/research-library/car-t-cell-therapy-market.html
Chimeric Antigen Receptor (CAR) T-cell
Therapy Market (2022-27): Segmentation Outlook
The market report
has segmented the market into the following categories:
·
Drug Class
o Yescarta (axicabtagene ciloleucel)
o Kymriah (tisagenlecleucel)
o Tecartus (brexucabtagene autoleucel)
o Breyanzi (lisocabtagene maraleucel)
o Others (Abecma (Idecabtagene vicleucel), etc.)
According to
report, Amongst all drugs, Yescarta holds the largest share in the Global
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, and the same trend is
likely to be followed during 2022-27.
·
By Application
o Acute Lymphocytic Leukemia (ALL)
o Diffuse Large B-cell Lymphoma (DLBCL)
o Follicular Lymphoma
o Multiple Myeloma
o Others (Mantle Cell Lymphoma, etc.)
According to
report, Here, Diffuse Large B-cell Lymphoma (DLBCL), followed by Acute
Lymphocytic Leukemia (ALL), dominates the market with the largest share.
·
By End-User
o Hospitals
o Clinics
o Specialty Cancer Centers
·
By Region
o North America
o South America
o Europe
o Middle East & Africa
o Asia-Pacific
Note - If there are any particular details
you need that are not currently included in the report, we will be happy to
provide them as part of our customization
services.
Top Companies Operating in the Chimeric
Antigen Receptor (CAR) T-cell Therapy Market:
- Amgen Inc.
- Bluebird Bio, Inc.
- Bristol Myers Squibb
- CARsgen Therapeutics
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Novartis International AG
- Pfizer Inc.
- Sorrento Therapeutics, Inc.
- Others
Reports Delivery Format - Market research
studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint
formats. Within 24 hours of the payment being successfully received, the report
will be sent to your email address
About Us –
We are a leading
market research company, consulting, & data analytics firm that provides an
extensive range of strategic reports on diverse industry verticals. We deliver
data to a substantial & varied client base, including multinational
corporations, financial institutions, governments, & individuals, among
others.
Our specialization
in niche industries & emerging geographies allows our clients to formulate
their strategies in a much more informed way and entail parameters like
Go-to-Market (GTM), product development, feasibility analysis, project scoping,
market segmentation, competitive benchmarking, market sizing & forecasting,
& trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564
Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate
Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Comments
Post a Comment